Marrone Bio Innovations, Inc. (MBII) Stock Up After Upgrade at Zacks Investment Research

Marrone Bio Innovations, Inc. (NASDAQ: MBII) shares rose in value on Wednesday January 18 on slower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, in early trade today, the S&P 500 SPX, +0.00% was off 2 points, or 0.1%, at 2,265, shortly after open. The Nasdaq Composite COMP, +0.20% was flat at 5,537. The Dow Jones Industrial Average DJIA, -0.20% slipped 54 points or 0.3%, to 19,770.

Analysts at Zacks Investment Research upgraded shares of Marrone Bio Innovations, Inc. (NASDAQ: MBII) from Sell to Hold today. The company currently has a rating of Hold on the shares. The one-year price target of $2.67 is higher than the opening price of $2.38, that has caused a number of other analysts to comment on the stock in recent days. Looking back over the last year, Marrone Bio Innovations, Inc. stock has a high of $2.79. Share prices sometimes get a boost to the upside when analysts upgrade a stock.

Yesterday Marrone Bio Innovations, Inc. (NASDAQ: MBII) shares last traded at $2.32, which represents a jump of $0.04 from the previous closing price. Opening at $2.38, they varied from $2.32 and $2.39 throughout the day.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) currently has a market cap of 57.21M.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) Average Daily Trading Volume

The stock’s average daily volume is 79,311 shares out of a total float 19,676,000 and some 2,767 shares traded hands yesterday, 61 percent lower than the average. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain substantial teams of analysts researching thousands of stocks, so it is good validation to see them buying a stock you are considering.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, Marrone Bio Innovations, Inc. (NASDAQ: MBII) now has a 50-day MA of $2.27 and 200-day MA of $1.70. It has traded in a 52-week range between $0.60 – 2.79 and today’s last price is 16.85%% lower than the 52 week high of $2.79.

Earnings growth is a crucial factor to research when investing in stocks and investors identify companies that have raised their earnings by at least 25% for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply